Local cancer drug approved for first clinical trial in United States and New Zealand
30 August 2012
The US Food and Drug Administration (FDA) has granted approval for PR610, an anticancer “stealth” drug invented in New Zealand, to move forward to human clinical trials through its approval of an Investigational New Drug (IND) Application for the drug.
New Zealand excellence in drug discovery attracts Asian science leaders
24 August 2012
A large delegation of science leaders from Asian industrial capitals is today visiting the Maurice Wilkins Centre to build relationships that will link New Zealand inventors into innovation networks within Asia.